AptaBio Therapeutics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	7,823	16,079	25,542	25,016	1,989
Short-Term Investments	1,017	1,112	1,020	19,000	15,026
Trading Asset Securities	-	-	4,954	8,869	-
Cash & Short-Term Investments	8,840	17,190	31,515	52,885	17,015
Cash Growth	-64.53%	-45.45%	-40.41%	210.81%	-
Accounts Receivable	757.31	591.25	893.71	-	-
Other Receivables	181.88	104.64	238.05	366.31	224.46
Receivables	1,031	3,195	1,435	2,659	3,047
Inventory	725.89	612.76	224.87	-	-
Prepaid Expenses	82.64	35.28	208.43	176.31	88.23
Other Current Assets	5,880	4,318	1,552	1,754	268.93
Total Current Assets	16,559	25,351	34,935	57,474	20,419
Property, Plant & Equipment	5,773	5,861	4,962	5,129	5,848
Long-Term Investments	26,605	26,298	30,986	23,779	27,885
Goodwill	1,020	1,020	-	-	-
Other Intangible Assets	29.4	32.87	39.35	61.09	37.83
Other Long-Term Assets	1,361	1,464	3,611	3,675	1,924
Total Assets	53,748	60,027	77,434	92,519	56,114
Accounts Payable	127.67	30.42	1.87	-	-
Accrued Expenses	558.41	813.24	609.79	337.19	455.54
Short-Term Debt	4,516	4,234	7,244	-	-
Current Portion of Leases	127.95	157.86	154.6	131.08	109.73
Current Income Taxes Payable	-	-	-	1.48	-
Other Current Liabilities	4,308	4,480	11,529	348.2	474.75
Total Current Liabilities	9,638	9,715	19,540	817.95	1,040
Long-Term Debt	-	-	-	13,569	-
Long-Term Leases	14.95	30.51	122.01	233.45	256.3
Pension & Post-Retirement Benefits	3,110	3,006	3,503	3,011	2,393
Other Long-Term Liabilities	90.31	90.58	71.4	13,524	54.58
Total Liabilities	12,854	12,842	23,237	31,156	3,744
Common Stock	14,047	14,047	13,441	11,149	11,149
Additional Paid-In Capital	157,922	157,922	149,733	129,712	109,025
Retained Earnings	-132,732	-126,278	-110,112	-80,713	-68,473
Comprehensive Income & Other	1,658	1,494	1,135	696.37	668.63
Total Common Equity	40,895	47,185	54,197	60,845	52,370
Shareholders' Equity	40,895	47,185	54,197	61,363	52,370
Total Liabilities & Equity	53,748	60,027	77,434	92,519	56,114
Total Debt	4,659	4,422	7,521	13,934	366.03
Net Cash (Debt)	4,181	12,768	23,994	38,951	16,649
Net Cash Growth	-75.34%	-46.79%	-38.40%	133.95%	-
Net Cash Per Share	151.72	474.51	1019.29	1746.78	746.98
Filing Date Shares Outstanding	28.14	28.09	26.88	22.3	22.3
Total Common Shares Outstanding	28.14	28.09	26.88	23.34	22.3
Working Capital	6,922	15,636	15,395	56,656	19,379
Book Value Per Share	1453.10	1679.56	2016.16	2607.28	2348.53
Tangible Book Value	39,845	46,131	54,158	60,784	52,332
Tangible Book Value Per Share	1415.80	1642.07	2014.69	2604.66	2346.83
Land	2,115	2,115	1,787	1,787	1,922
Buildings	4,123	4,123	3,215	3,046	3,388
Machinery	1,347	1,337	1,268	1,196	1,101